Komori
Governance4540TSUMURA & CO.Pharmaceuticals

Corporate Governance Report 2026/04/01

The report outlines the remuneration system and the decision-making and approval procedures for timely disclosure. It explains the framework under which outside directors constitute a majority of the Board of Directors and the Remuneration Advisory Committee is used to enhance the objectivity and transparency of remuneration decisions.

Worth reading
66In focus
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Committee2
Remuneration Advisory Committee: the chair is an outside directorand outside directors constitute a majority of the members. For the Nomination Committee: 非開示
Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
CommitteeRemuneration Advisory Committee: the chair is an outside director, and outside directors constitute a majority of the members. For the Nomination Committee: Not disclosed
Items this document does not state (6)
Number of directorsNumber of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To achieve the long-term management vision and medium-term management plan, drive sustainable growth, earn the trust of stakeholders, address social issues, and improve the objectivity and transparency of remuneration decision-making procedures.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Corporate Governance Report 2026/04/01 | TSUMURA & CO. (4540) timely disclosure | Komori